Sachetta’s Moderna MRNA Stock Holding History

Sachetta’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.2K	Buy	217 +3	+1%	+$155	0.01%	360
2026 Q1	$10.9K	Sell	214 -96	-31%	-$4.48K	0.01%	427
2025 Q4	$9.14K	Sell	310 -27	-8%	-$734	0.01%	419
2025 Q3	$8.71K	Sell	337 -157	-32%	-$4.38K	﹤0.01%	495
2025 Q2	$13.6K	Sell	494 -81	-14%	-$2.13K	0.01%	394
2025 Q1	$16.3K	Sell	575 -422	-42%	-$15K	0.01%	373
2024 Q4	$41.5K	Sell	997 -11	-1%	-$526	0.02%	283
2024 Q3	$67.4K	Buy	1,008 +455	+82%	+$41.8K	0.03%	244
2024 Q2	$65.7K	Sell	553 -13	-2%	-$1.65K	0.03%	228
2024 Q1	$56.3K	Hold	566	–	–	0.03%	237
2023 Q4	$56.3K	Buy	+566	New	+$47.6K	0.03%	237

Other funds holding MRNA

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

OIAM

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

MIM

Morningstar Investment Management Chicago, Illinois $1.62B AUM 13.96% 1-Year Est. Return

LAI

Legal Advantage Investments Los Altos Hills, California $285M AUM 18.63% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

Sachetta's MRNA Position: Q2 2026 in Review

Sachetta increased its Moderna (MRNA) stake by 1.4% in Q2 2026, buying an estimated $155 and bringing the position to 217 shares worth $15.2K. The position accounts for 0.01% of the portfolio, ranked #360.

Sachetta first reported a position in MRNA in Q4 2023 and has held it in 11 quarters since. The position peaked at $67.4K in Q3 2024. 145 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Sachetta held 217 shares of Moderna worth $15.2K as of Q2 2026.
Sachetta bought 3 Moderna shares in Q2 2026, an estimated $155.
Moderna made up 0.01% of Sachetta's portfolio in Q2 2026, its #360 holding.
Sachetta first reported a position in Moderna in Q4 2023 and has held it in 11 quarters since.
Sachetta's Moderna position peaked at $67.4K in Q3 2024.
145 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Sachetta's 13F filing for Q2 2026, filed 15 Jul 2026.